Biopremier – Innovation and Services in Biotechnology, S.A.
Biopremier – Innovation and Services in Biotechnology, S.A.: Biopremier receives the accreditation of two clinical tests for the veterinarian sector
Biopremier - Innovation and Services in Biotechnology, S.A. / Key word(s): Regulatory Approval/Product Launch 25.01.2012 / 08:15 --------------------------------------------------------------------- Biopremier receives the accreditation of two clinical tests for the veterinarian sector - Accreditation of two clinical tests for the veterinarian sector - Accreditation valid for the European market - Market volume of 2.2 million Euro in Portugal respectively 130 million Euro in Europe - Currently focus on marketing its portfolio Lisbon, the 25th of January 2012 - Biopremier, an early to mid-stage Portuguese Biotech company active in the food analysis and the clinical diagnostics sector today announces that it had received the accreditation of two clinical tests for the veterinarian sector according to the ISO 17025 standard. This accreditation is valid for the European market. Both tests are mainly focused on the veterinary sector whereby the test for the detection of Mycoplasmatales has a potential market volume of around 0.7 million Euro in Portugal, respectively around 30 million Euro in Europe. The second test, regarding the detection of Dermatophytes has potential market volume of 1.5 million Euro in Portugal, respectively 100 million Euro in Europe. The advantage of the now accredited tests of Biopremier is that the detection of Dermatophytes by PCR delivers results in 24 to 48 hours instead two to three weeks using traditional methods. Furthermore the tests offer a high level of specificity and sensibility. The detection of Mycoplasmatales by PCR delivers as well results within 24 to 48 hours that is also much quicker than the traditional methods that may need around one week to show results. Currently Biopremier has a portfolio of 27 tests of which nine are unique in Europe. Now, the focus of the company is to market its portfolio within the European countries. Therefore negotiations with selected market players have been initiated already. Manuel Rodrigues, CEO of Biopremier: 'We are delighted having received the accreditation of 2 additional tests. This accreditation according to the ISO Standards - being valid in whole Europe - reflects our hard work and our focus on efficient and accurate solutions for the clinical sector. Currently we are working on the development of further tests and we expect having a portfolio of around 42 accredited tests by the end of the year.' About Biopremier The track record of Biopremier includes 27 accredited tests according to the ISO Standard 17025, fully developed and validated in-house. Biopremier is one of the few Portuguese accredited laboratories for clinical and veterinary diagnostics and food-analysis, and the only private entity in Portugal enjoying accreditation of its DNA-based tests. Furthermore Biopremier has a highly qualified staff (14) composed of researchers with 15 years of relevant experience. The Company enjoys close collaborations with relevant clinical pathologists and veterinaries, helping to define the products that fit the needs of health professionals. Currently, Biopremier is developing its first products to be sold as a kit for the clinical use, which are anticipated to be launched in 2013. In the agri-food sector Biopremier is already working for multinational groups in Portugal and other Southern European countries. Contact Biopremier S.A. E-mail: ir@biopremier.com Fax: +351 - 217 500 432 Dr. Manuel Rodrigues, Tel.: +351 217 500 218 This press release serves information purposes exclusively and it does not constitute an offer, nor a request to submit an offer, to acquire or subscribe shares of Biopremier S.A.. End of Corporate News --------------------------------------------------------------------- 25.01.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 153841 25.01.2012
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden